background image
Johnson MD, Perfect JR. Caspofungin: first approved agent in a new class of antifungals. Expert
Opin Pharmacother. 2003;4:807­823.
Jones RN, Hare RS, Sabatelli FJ, et al. In vitro gram-positive antimicrobial activity of evernimicin
(SCH 27899), a novel oligosaccharide, compared with other antimicrobials: a multicentre
international trial. J Antimicrob Chemother. 2001;47:15­25.
Jones RN, Huynh HK, Biedenbach DJ. Activities of doripenem (S-4661) against drug-resistant
clinical pathogens. Antimicrob Agents Chemother. 2004;48:3136­3140.
Klein JO. Amoxicillin/clavulanate for infections in infants and children: past, present and future.
Pediatr Infect Dis J. 2003;22(8 suppl):S139­148.
Mercier RC, Kennedy C, Meadows C. Antimicrobial activity of tigecycline (GAR-936) against
Enterococcus faecium and Staphylococcus aureus used alone and in combination.
Pharmacotherapy. 2002;22:1517­1523.
Montecalvo MA. Ramoplanin: a novel antimicrobial agent with the potential to prevent
vancomycin-resistant enterococcal infection in high-risk patients. J Antimicrob Chemother.
2003;51(suppl 3):31­35.
Peck R, Gimple SK, Gregory DW, et al. Progressive outer retinal necrosis in a 73-year-old man:
treatment with valganciclovir. AIDS. 2003;17(7):1110­1111.
Rybak MJ, Hershberger E, Moldovan T, et al. In vitro activities of daptomycin, vancomycin,
linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including
vancomycin-intermediate and -resistant strains. Antimicrob Agents Chemother.
2000;44:1062­1066.
Savant V, Saeed T, Denniston A, et al. Oral valganciclovir treatment of varicella zoster virus
acute retinal necrosis. Eye. 2004;18(5):544­545.
Spiers KM, Zervos MJ. Telithromycin. Expert Rev Anti Infect Ther. 2004;2:685­693.
Stevens DL, Dotter B, Madaras-Kelly K. A review of linezolid: the first oxazolidinone antibiotic.
Expert Rev Anti Infect Ther. 2004;2:51­59.
Welliver R, Monto AS, Carewicz O, et al. Effectiveness of oseltamivir in preventing influenza in
household contacts. A randomized controlled trial. JAMA. 2001;285:748­754.
Bölüm 1:
Enfeksiyon Hastal>klar>
·
79